The largest database of trusted experimental protocols

15 protocols using cd4 cd25 treg isolation kit

1

In vitro Treg Cell Differentiation and Polarization

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro induced Treg (iTreg) cells were differentiated as previously described (15 (link)). Briefly, CD4+CD25 cells were negatively selected from B6 or Pbx1-d Tg splenocytes using the CD4+CD25+ Treg isolation kit (Miltenyi Biotech), and then 5 × 105 cells were stimulated with mouse T-activator CD3/CD28 beads (Life Technologies) at the concentration of 1 × 106 beads/mL in the presence of 100 U IL-2, 20 ng/ml TGF-β (Pepro Tech), and 0–5 nM all-trans retinoic acid (RA) for 5 d. TH1 and TH17 polarization was performed as previously described (23 ).
+ Open protocol
+ Expand
2

Isolation of Human Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMC) were isolated from freshly collected blood of healthy volunteers or from buffy coats by Ficoll density-gradient centrifugation (PAA Laboratories, Pasching, Austria). Treg isolation was performed using the CD4+CD25+ Treg isolation kit (Miltenyi Biotech, Bergisch Gladbach, Germany) according to the manufacturer’s recommendations. This study was approved by the Charité-Universitätsmedizin Berlin ethics committee (Institutional Review Board) and all blood donors provided written informed consent.
+ Open protocol
+ Expand
3

Isolation of CD4+CD25+ Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
From pooled splenocytes, CD4+CD25+ cells were purified using CD4+CD25+ Treg isolation kit (Miltenyi Biotec Inc., Auburn, CA) according to the manufacturer's protocol. CD4+CD25- cells were obtained by collecting the flow through cells during positive selection of CD4+CD25+ cells. Confirmation of >80% purity was performed by FACS before in vitro culture.
+ Open protocol
+ Expand
4

Isolation of Human Peripheral Tregs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Written informed consent to participate in the study was obtained from the patients and donors before blood sampling. Blood samples were obtained via venipuncture into vacuum tubes with K2EDTA anticoagulant. Density gradient centrifugation using 1.077 g/mL Ficoll (Paneco, Moscow, Russia) was used to obtain peripheral blood mononuclear cells. Then, Tregs were isolated from peripheral blood mononuclear cells by immune-magnetic separation using the CD4+CD25+Treg isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany).
+ Open protocol
+ Expand
5

Adoptive Transfer of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes from WT, PD-1 KO, T-bet Tg and P/T mice were isolated and single-cell suspensions were prepared in PBS. Splenic cells (1·0 × 107) were injected intravenously into the recipient adult Rag-2 KO mice. In other experiments, the CD4+CD25+ Tregs were isolated from splenocytes of WT mice using CD4+CD25+ Treg isolation kit (Miltenyi Biotec). The purity of all populations was determined with FACS before injection. Mice were observed every other day for clinical signs of autoimmune syndromes. Histological determination of autoimmune responses against various organs and tissues was conducted at 10 weeks after transfer.
+ Open protocol
+ Expand
6

CD4+ CD25+ T Cell Isolation and Adoptive Transfer

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were purified from spleens of WT and Gpr174 KO mice, mechanically disrupted over a 75 μm filter, and subjected to magnetic bead enrichment for CD4+CD25+ T cells using CD4+CD25+ Treg isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Enriched CD4+CD25+ T cells were counted and resuspended in PBS. A cell suspension containing 1 × 106 per 100 μl PBS was injected into C57BL/6 Rag2−/− mouse via tail vein.
+ Open protocol
+ Expand
7

In Vitro Suppression Assay of Regulatory T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ CD25effector T cells and CD4+ CD25+ Tregs were isolated from B6 or B6.SLE123 spleens by using a CD4+ CD25+ Treg isolation kit (Miltenyi, San Diego, CA). Effector CD4 T cells and CD4Tregs were resuspended in complete RPMI media (10% fetal calf serum plus 1% penicillin/streptomycin) and plated in 96-well round-bottomed plates at Treg:T effector ratios ranging from 1:2 to 1:8 (8 (link)). Cells were stimulated with anti-CD3 (1 µg/mL, 145-2C11; BD) and anti-CD28 (1 µg/mL, 37.51; BD) and incubated for 72 h. For transforming growth factor-β (TGF-β) suppression assays, splenocytes were incubated with anti-CD3/CD28 (1 µg/mL) with or without 10 µg/mL TGF-β (R&D Systems, Minneapolis, MN) for 72 h. Supernatants were collected and analyzed for interferon-γ (IFNγ) by enzyme-linked immunosorbent assay (ELISA) (BD). The percent suppression was calculated as follows: [(IFNγ production in each condition/IFNγ T effector cells only) * 100].
+ Open protocol
+ Expand
8

T Cell Proliferation and Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
As presented in Supplementary figure 1, Treg (CD4+CD25high) and effector T cells (CD4+CD25low; Teff) were purified from fresh PBMCs by magnetic cell sorting following the manufacturers' instructions (CD4+CD25+ Treg Isolation Kit; Miltenyi Biotec, Paris, France). Teff and Treg were labelled with CellTrace Violet and CFSE (Thermo Fisher Scientific, Invitrogen, VILLEBON‐SUR‐YVETTE, France), respectively. T cells were activated with anti‐CD2/CD3/CD28 microbeads (Miltenyi Biotec) and cultured with or without Treg (Teff:Treg ratio = 2:1) or tocilizumab (5 µg mL−1). After 4 days, cells were activated with 0.1 µg mL−1 of phorbol 12‐myristate 13‐acetate (PMA) and 1 µg mL−1 of ionomycin (Sigma‐Aldrich, Saint‐Quentin‐Fallavier, France) in the presence of Brefeldin A (BD Golgi Plug; BD Bioscience, Le Pont‐de‐Claix, France) for 4 h and then fixed, permeabilised and stained with CD4‐PECy7, IL‐17‐PE and IFN‐γ‐APC. CellTrace Violet or CFSE incorporation and cytokine expression were analysed by flow cytometry to determine the proliferation index of Teff and Treg and the percentage of Th1 (CD4+IFN‐γ+) and Th17 (CD4+IL‐17+) cells among Teff (CD4+CFSE) and Treg (CD4+CFSE+).
+ Open protocol
+ Expand
9

Intracellular Transcription Factor Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Foxp3, cells were stained with anti-Foxp3 (eBioscience) using a Foxp3 staining kit (BioLegend). For YY1 staining, total splenocytes from YY1-eGFP mice were enriched by CD4 microbeads (Miltenyi). Tconv (CD4+CD25) or Treg (CD4+ CD25+) cells from WT mice were prepared using a CD4+CD25+ Treg isolation kit (Miltenyi). The cells were stained with an anti-YY1 (Santa Cruz sc-1703) antibody using a Foxp3 staining kit (BioLegend). For cytokine staining, cells were restimulated with 1 μM ionomycin (Sigma-Aldrich) and 10 nM phorbol myristate acetate (Sigma-Aldrich) with Golgi stop (BD Bioscience) for 4 h. Intracellular staining was performed using Cytofix/cytoperm kit (BD Bioscience).
+ Open protocol
+ Expand
10

Isolation of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+CD25+ Tregs and CD4+CD25 responder T cells (Tresp) were isolated from lymph nodes of naïve BALB/c mice by magnetic assisted cell sorting using the CD4+CD25+ Treg Isolation Kit (Miltenyi Biotec, Bergisch-Gladbach, Germany). NK cells were sorted from draining lymph nodes and splenocytes of BALB/c mice using the NK Cell Isolation Kit II (Miltenyi Biotec). Purity of isolated Tregs was >90% as measured by flow cytometry. Antigen presenting cells (APCs) were obtained by depleting T cells (CD90.2+ cells) from splenocytes of BALB/c mice using a CD90.2 isolation kit (Miltenyi Biotec).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!